Full Press Release Details
Biotech Ltd. Files Annual Report on Form 20-F
May 1, 2009, 12:37 pm EDT
May 1 /PRNewswire-FirstCall/ -- Sinovac Biotech Ltd. (NYSE Amex: SVA), a leading
developer and provider of vaccines in China, today announced that it has filed
its Annual Report on Form 20-F with the U.S. Securities and Exchange Commission
for the year ended December 31, 2008 on May 1, 2009. The Annual Report on Form
20-F is now available on the Company's website under the investor relations
section at: http://www.sinovac.com/Investors/SECFilings/.
Company will provide a hard copy of its complete audited financial statements to
its shareholders free of charge upon request. Requests for a hard copy of the
2008 annual report can be processed by visiting the Investor Relations section
of the Company's website and filling in the complete mailing details on the
Biotech Ltd. is a China-based biopharmaceutical company that focuses on the
research, development, manufacture and commercialization of vaccines that
protect against human infectious diseases. Sinovac's commercialized vaccines
include Healive (hepatitis A), Bilive (combined hepatitis A and B), and Anflu
(influenza). Panflu(TM) , Sinovac's pandemic influenza vaccine (H5N1), has
already been approved for government stockpiling. Sinovac is developing vaccines
for Enterovirus 71, Universal Pandemic Influenza, Japanese encephalitis vaccine,
and Human Rabies vaccine. Its wholly-owned subsidiary, Tangshan Yian, is
conducting field trials for independently developed inactivated animal rabies
announcement contains forward-looking statements. These statements are made
under the "safe harbor" provisions of the U.S. Private Securities Litigation
Reform Act of 1995. These forward-looking statements can be identified by words
or phrases such as "will," "expects," "anticipates," "future," "intends,"
"plans," "believes," "estimates" and similar statements. Among other things, the
business outlook and quotations from management in this press release contain
forward-looking statements. Statements that are not historical facts, including
statements about Sinovac's beliefs and expectations, are forward-looking
statements. Forward-looking statements involve inherent risks and uncertainties.
A number of important factors could cause actual results to differ materially
from those contained in any forward-looking statement. Sinovac does not
undertake any obligation to update any forward-looking statement, except as
required under applicable law.
more information, please contact:
+86-10-8289-0088 x9871
+1-646-536-7023/7002